2020
DOI: 10.1111/dth.14164
View full text
|
Sign up to set email alerts
|
Share

Abstract: New-generation dermal fillers-more differentiated and long-lastinghave been developed to maintain the lasting effects of HA fillers. Juvéderm Voluma XC is a new-generation filler produced using Vycross (VYC) technology. Interestingly, with the introduction of the VYC technology, the incidence of delayed adverse events (DAE) has increased. 1,2 Recently, it has been reported and published that the incidence risk of DAE after VYC fillers is around 1.0%. 3 We report a case of DAE to two new HA gels: Juvéderm Volum…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
0
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals